FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fredrik Jarskog

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Co-author Network

Publications

TOP 3
L Fredrik Jarskog; Daniel C Javitt; Alayar Kangarlu; Richard Se Keefe; Lawrence S Kegeles; Stephen R Marder; Joseph P McEvoy; Robert P McMahon; Bradley S Peterson; Deanna M Barch; Robert W Buchanan; Tiziano Colibazzi; John G Csernansky; Zhengchao Dong; Ragy R Girgis; Donald C Goff; Michael P Harms; Jeffrey A Lieberman
Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia.
Cort A Pedersen; Shane W Rau; Kelly L Smedley; Robin L Casey; Trace Fender; L Fredrik Jarskog; Alexei Kampov-Polevoi; Jane Madison; James C Garbutt
Intranasal oxytocin blocks alcohol withdrawal in human subjects.
S Miyamoto; N Miyake; W W Fleischhacker; L Fredrik Jarskog; Jeffrey A Lieberman
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fredrik Jarskog (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L Fredrik Jarskog; Daniel C Javitt; Alayar Kangarlu; Richard Se Keefe; Lawrence S Kegeles; Stephen R Marder; Joseph P McEvoy; Robert P McMahon; Bradley S Peterson; Deanna M Barch; Robert W Buchanan; Tiziano Colibazzi; John G Csernansky; Zhengchao Dong; Ragy R Girgis; Donald C Goff; Michael P Harms; Jeffrey A Lieberman
Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(7):1245-52.
2013: Cort A Pedersen; Shane W Rau; Kelly L Smedley; Robin L Casey; Trace Fender; L Fredrik Jarskog; Alexei Kampov-Polevoi; Jane Madison; James C Garbutt
Intranasal oxytocin blocks alcohol withdrawal in human subjects.
Alcoholism, clinical and experimental research 2013;37(3):484-9.
2012: S Miyamoto; N Miyake; W W Fleischhacker; L Fredrik Jarskog; Jeffrey A Lieberman
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
Molecular psychiatry 2012;17(12):1206-27.
2012: Nobumi Miyake; Seiya Miyamoto; L Fredrik Jarskog
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Clinical schizophrenia & related psychoses 2012;6(3):122-33.
2012: L Fredrik Jarskog
Advantages and limitations of newer antipsychotics: evidence from large comparative trials.
Clinical schizophrenia & related psychoses 2012;6(3):113-4.
2012: Jürgen Kayser; Christopher J Kroppmann; Craig E Tenke; Daniel M Alschuler; Shiva Fekri; Roberto Gil; Jill M Harkavy-Friedman; L Fredrik Jarskog; Gerard E Bruder
A neurophysiological deficit in early visual processing in schizophrenia patients with auditory hallucinations.
Psychophysiology 2012;49(9):1168-78.
2011: Cort A Pedersen; Shane W Rau; Kayvon Salimi; Kelly L Smedley; Robin L Casey; Clare M Gibson; L Fredrik Jarskog; Jane Madison; David L Penn
Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
Schizophrenia research 2011;132(1):50-3.
2011: Andrew J Rosenfeld; Jeffrey A Lieberman; L Fredrik Jarskog
Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.
Schizophrenia bulletin 2011;37(5):1077-87.
2011: Robert W Buchanan; Richard S E Keefe; Jeffrey A Lieberman; Deanna M Barch; John G Csernansky; Donald C Goff; James M Gold; Michael F Green; L Fredrik Jarskog; Daniel C Javitt; David Kimhy; Michael S Kraus; Joseph P McEvoy; Raquelle I Mesholam-Gately; Larry J Seidman; M Patricia Ball; Robert P McMahon; Robert S Kern; James Robinson; Stephen R Marder
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.
Biological psychiatry 2011;69(5):442-9.
2011: T Scott Stroup; L Fredrik Jarskog
No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ.
Evidence-based mental health 2011;14(1):25.
2010: Vanessa Toney Bobb; L Fredrik Jarskog; Barbara J Coffey
Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine.
Journal of child and adolescent psychopharmacology 2010;20(6):539-43.
2010: T Scott Stroup; L Fredrik Jarskog
Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia.
Evidence-based mental health 2010;13(2):53.
2010: Leisa A Glantz; John Gilmore; David H Overstreet; Kayvon Salimi; Jeffrey A Lieberman; L Fredrik Jarskog
Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.
Schizophrenia research 2010;118(1-3):292-9.
2009: Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Antipsychotic drugs for first-episode schizophrenia: a comparative review.
CNS drugs 2009;23(10):837-55.
2009: Leon G Coleman; L Fredrik Jarskog; Sheryl S Moy; Fulton T Crews
Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatment.
Pharmacology, biochemistry, and behavior 2009;93(3):322-30.
2009: E T Cox; L H Brennaman; Karissa L Gable; Robert M Hamer; Leisa A Glantz; Anthony-Samuel LaMantia; Jeffrey A Lieberman; John Gilmore; Patricia F Maness; L Fredrik Jarskog
Developmental regulation of neural cell adhesion molecule in human prefrontal cortex.
Neuroscience 2009;162(1):96-105.
2008: Maile A Henson; Adam C Roberts; Kayvon Salimi; Swarooparani Vadlamudi; Robert M Hamer; John Gilmore; L Fredrik Jarskog; Benjamin D Philpot
Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex.
Cerebral cortex (New York, N.Y. : 1991) 2008;18(11):2560-73.
2008: Kayvon Salimi; Leisa A Glantz; Robert M Hamer; Thomas T German; John Gilmore; L Fredrik Jarskog
Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortex.
Synapse (New York, N.Y.) 2008;62(4):273-82.
2007: Leisa A Glantz; John Gilmore; Robert M Hamer; Jeffrey A Lieberman; L Fredrik Jarskog
Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood.
Neuroscience 2007;149(3):582-91.
2007: Jeffrey A Lieberman; Diana O Perkins; L Fredrik Jarskog
Neuroprotection: a therapeutic strategy to prevent deterioration associated with schizophrenia.
CNS spectrums 2007;12(3 Suppl 4):1-13; quiz 14.
2007: Diana O Perkins; Clark Jeffries; L Fredrik Jarskog; J Michael Thomson; Keith Woods; Martin A Newman; Joel Parker; Jianping Jin; Scott M Hammond
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.
Genome biology 2007;8(2):R27.
2007: L Fredrik Jarskog; Seiya Miyamoto; Jeffrey A Lieberman
Schizophrenia: new pathological insights and therapies.
Annual review of medicine 2007;58():49-61.
2007: L Fredrik Jarskog; John Gilmore; Leisa A Glantz; Karissa L Gable; Thomas T German; Ruth I Tong; Jeffrey A Lieberman
Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):95-102.
2006: L Fredrik Jarskog; Jeffrey A Lieberman
Neuroprotection in schizophrenia.
The Journal of clinical psychiatry 2006;67(9):e09.
2006: Jeffrey A Lieberman; L Fredrik Jarskog; Dolores Malaspina
Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
The Journal of clinical psychiatry 2006;67(6):983-90.
2006: L Fredrik Jarskog
Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations.
Current opinion in psychiatry 2006;19(3):307-12.
2006: Jeffrey A Lieberman; Dolores Malaspina; L Fredrik Jarskog
Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
CNS spectrums 2006;11(4):suppl 1-13; quiz suppl 14-5.
2006: Leisa A Glantz; John Gilmore; Jeffrey A Lieberman; L Fredrik Jarskog
Apoptotic mechanisms and the synaptic pathology of schizophrenia.
Schizophrenia research 2006;81(1):47-63.
2005: L Fredrik Jarskog; Leisa A Glantz; John Gilmore; Jeffrey A Lieberman
Apoptotic mechanisms in the pathophysiology of schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(5):846-58.
2005: John Gilmore; L Fredrik Jarskog; Swarooparani Vadlamudi
Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat.
Journal of neuroimmunology 2005;159(1-2):106-12.
2004: Sayed S Alamy; L Fredrik Jarskog; Brian Sheitman; Jeffrey A Lieberman
Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features.
Schizophrenia research 2004;66(2-3):183-6.
2004: Brian Sheitman; Michael B Knable; L Fredrik Jarskog; Miranda Chakos; Leslie Boyce; John Early; Jeffrey A Lieberman
Secretin for refractory schizophrenia.
Schizophrenia research 2004;66(2-3):177-81.
2004: L Fredrik Jarskog; Elzbieta S Selinger; Jeffrey A Lieberman; John Gilmore
Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation.
The American journal of psychiatry 2004;161(1):109-15.
2003: John Gilmore; L Fredrik Jarskog; Swarooparani Vadlamudi
Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat.
Journal of neuroimmunology 2003;138(1-2):49-55.
2002: Baruch Spivak; Sayed S Alamy; L Fredrik Jarskog; Brian Sheitman; Jeffrey A Lieberman
Ziprasidone alternative for olanzapine-induced hyperglycemia.
The American journal of psychiatry 2002;159(9):1606.
2001: Christine E Marx; L Fredrik Jarskog; Jean M Lauder; Jeffrey A Lieberman; John Gilmore
Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia.
Biological psychiatry 2001;50(10):743-9.
2001: A Urakubo; L Fredrik Jarskog; Jeffrey A Lieberman; John Gilmore
Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain.
Schizophrenia research 2001;47(1):27-36.
2000: L Fredrik Jarskog; John Gilmore; Elzbieta S Selinger; Jeffrey A Lieberman
Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia.
Biological psychiatry 2000;48(7):641-50.
2000: Christine E Marx; L Fredrik Jarskog; Jean M Lauder; John Gilmore; Jeffrey A Lieberman; A Leslie Morrow
Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia.
Brain research 2000;871(1):104-12.
2000: Diana O Perkins; Jane Madison; L Fredrik Jarskog; Karen A Graham; J Kazmer; Jeffrey A Lieberman
Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory.
Schizophrenia research 2000;44(1):1-10.
2000: L Fredrik Jarskog; Mark Mattioli; Diana O Perkins; Jeffrey A Lieberman
First-episode psychosis in a managed care setting: clinical management and research.
The American journal of psychiatry 2000;157(6):878-84.
2000: L Fredrik Jarskog; John Gilmore
Developmental expression of Bcl-2 protein in human cortex.
Brain research. Developmental brain research 2000;119(2):225-30.
1999: Christine E Marx; B J Vance; L Fredrik Jarskog; Nancy C Chescheir; John Gilmore
Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 levels in human amniotic fluid.
American journal of obstetrics and gynecology 1999;181(5 Pt 1):1225-30.
1997: John Gilmore; L Fredrik Jarskog; J C Lindgren; J P McEvoy; H Xiao
Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness.
Psychiatry research 1997;73(1-2):109-13.
1997: L Fredrik Jarskog; H Xiao; MB Wilkie; Jean M Lauder; John Gilmore
Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1997;15(6):711-6.
1997: John Gilmore; L Fredrik Jarskog
Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia.
Schizophrenia research 1997;24(3):365-7.